Phase
Condition
Carcinoma
Scalp Disorders
Allergy
Treatment
N/AClinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Pathologically confirmed and previously untreated nasopharyngeal carcinoma.
Age ≥ 18 years and ≤ 65 years.
Karnofsky performance status (KPS) score ≥ 70.
No prior radiation or surgery in the head and neck.
No contraindication to radiotherapy.
Planned to receive radiotherapy alone or concurrent chemoradiotherapy, withintensity-modulated radiation therapy (IMRT).
Adequate bone marrow function: while blood cell >= 3,000/μL, absolute neutrophil count >= 1,500/μL, hemoglobin >= 100g/L, platelet >= 75,000/μL.
Life expectancy of >= 3 months.
Exclusion
Exclusion Criteria:
Known allergic reaction to any component of Medical Radiation Protectants (FORRAD®) orTrolamine (Biafine), or severe allergic constitution.
Other conditions that the investigators consider as inappropriate for enrolling intothis study.
Study Design
Study Description
Connect with a study center
Department of Radiation Oncology, Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong 510060
ChinaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.